The Latest in Hematology Times

Quadruplet prolongs progression-free survival in newly diagnosed myeloma

September 26, 2019

CDC awards $1.2 million to learn about people with sickle cell disease

September 26, 2019

Anemia

Several factors may affect immune suppression discontinuation after HCT

September 26, 2019

ASCT may cure follicular lymphoma for some rituximab-naive patients

September 24, 2019

Oral triplet shows promise for relapsed/refractory myeloma

September 22, 2019

CAR T-cell therapy found safe, effective for HIV-associated lymphoma

September 20, 2019

Combo could be new standard for transplant-eligible, newly diagnosed myeloma patients

September 20, 2019

Adding elotuzumab to lenalidomide/dexamethasone can prolong survival in relapsed/refractory myeloma

September 19, 2019

CT103A elicits responses after prior CAR T-cell relapse

September 19, 2019

Worse PFS when radiation is withheld in early-stage Hodgkin lymphoma

September 19, 2019

Novel gene therapies show promise for sickle cell cure

September 19, 2019

Staging PET/CT better defines extent of mantle cell lymphoma

September 19, 2019

Lymphoma & Plasma Cell Disorders

Melflufen-dexamethasone active in patients with relapsed/refractory myeloma and EMD

September 19, 2019

Genetic analysis highlights value of germline variants in MDS, AML

September 18, 2019

Could home care replace inpatient HSCT?

September 18, 2019